In addition to CTLA‐4 and PD‐1, there are many other immune checkpoint molecules, including TIM‐3, LAG‐3, and TIGIT,3 which provide alternative targets that could be utilized to induce an anti‐tumor immune response. Here, HAVCR2 is linked to neoplasm.